- Home
- GDHG vs ADIL Comparison
GDHG vs ADIL Comparison
Compare GDHG & ADIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GDHG
- ADIL
- Stock Information
- Founded
- GDHG 2008
- ADIL 2010
- Country
- GDHG China
- ADIL United States
- Employees
- GDHG N/A
- ADIL N/A
- Industry
- GDHG Services-Misc. Amusement & Recreation
- ADIL Biotechnology: Pharmaceutical Preparations
- Sector
- GDHG Consumer Discretionary
- ADIL Health Care
- Exchange
- GDHG Nasdaq
- ADIL Nasdaq
- Market Cap
- GDHG 7.4M
- ADIL 6.5M
- IPO Year
- GDHG 2023
- ADIL 2018
- Fundamental
- Price
- GDHG $1.98
- ADIL $1.07
- Analyst Decision
- GDHG
- ADIL Strong Buy
- Analyst Count
- GDHG 0
- ADIL 1
- Target Price
- GDHG N/A
- ADIL $8.00
- AVG Volume (30 Days)
- GDHG 55.2K
- ADIL 212.3K
- Earning Date
- GDHG 02-13-2025
- ADIL 11-13-2024
- Dividend Yield
- GDHG N/A
- ADIL N/A
- EPS Growth
- GDHG N/A
- ADIL N/A
- EPS
- GDHG 1.62
- ADIL N/A
- Revenue
- GDHG $25,549,903.00
- ADIL N/A
- Revenue This Year
- GDHG N/A
- ADIL N/A
- Revenue Next Year
- GDHG N/A
- ADIL N/A
- P/E Ratio
- GDHG $1.22
- ADIL N/A
- Revenue Growth
- GDHG N/A
- ADIL N/A
- 52 Week Low
- GDHG $1.40
- ADIL $0.77
- 52 Week High
- GDHG $59.00
- ADIL $4.17
- Technical
- Relative Strength Index (RSI)
- GDHG 55.59
- ADIL 48.27
- Support Level
- GDHG $1.77
- ADIL $1.05
- Resistance Level
- GDHG $1.97
- ADIL $1.16
- Average True Range (ATR)
- GDHG 0.21
- ADIL 0.09
- MACD
- GDHG 0.06
- ADIL -0.01
- Stochastic Oscillator
- GDHG 82.09
- ADIL 23.33
About GDHG Golden Heaven Group Holdings Ltd.
Golden Heaven Group Holdings Ltd is an offshore holding company. Through the operating entities in China, It manages and operates six properties consisting of amusement parks, water parks, and complementary recreational facilities. The parks offer a broad selection of exhilarating and recreational experiences, including both thrilling and family-friendly rides, water attractions, gourmet festivals, circus performances, and high-tech facilities. The parks collectively contain nearly 159 rides and attractions. The firm's revenue is generated from selling access to rides and attractions, charging fees for special event rentals, and collecting regular rental payments from commercial tenants.
About ADIL Adial Pharmaceuticals Inc
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. The active ingredient in AD04 is ondansetron, a serotonin-3 antagonist.